A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...

Researchers at the University of Pittsburgh have taken a step toward developing a bird flu vaccine. And their findings could ...

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of ...

The highly pathogenic avian influenza H5N1 infection has killed millions of birds around the world, and has spread to humans ...

The antibodies target a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and ...

All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...

Scientists found that a moderate dose of MEDI8852, an antibody therapy, effectively protected monkeys against severe H5N1 avian flu.

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.

A prophylactic antibody-based immune therapy has been shown to protect monkeys against severe bird flu caused by H1N1.